Codexis (CDXS) Common Equity (2010 - 2026)
Codexis' (CDXS) quarterly Common Equity came in at $43.2 million in Q1 2026, down 12.89% year-on-year from $49.6 million in Q1 2025, and down 14.44% quarter-over-quarter from $50.5 million in Q4 2025.
Codexis (CDXS) Common Equity (2010 - 2026) Analysis & Trends
Codexis' Common Equity history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.
- On a quarterly basis, Common Equity fell 12.89% year-over-year to $43.2 million in Q1 2026; TTM through Mar 2026 was $43.2 million, a 12.89% decrease from a year earlier, with the FY2025 full-year figure at $50.5 million, down 24.5% from the prior year.
- Common Equity eased to $43.2 million in Q1 2026 per CDXS's latest filing, from $50.5 million in the prior quarter.
- Across five years, Common Equity topped out at $159.5 million in Q2 2022 and bottomed at $38.5 million in Q3 2025.
- The 5-year median for Common Equity is $79.3 million (2024), against an average of $92.0 million.
- Across the five-year window, Common Equity declined 2.04% in 2022 and sank 50.5% in 2024, its largest moves.
- Year by year, Common Equity stood at $144.8 million in 2022, then sank by 40.18% to $86.6 million in 2023, then dropped by 22.73% to $66.9 million in 2024, then retreated by 24.5% to $50.5 million in 2025, then retreated by 14.44% to $43.2 million in 2026.
- Per Business Quant, the three latest CDXS Common Equity figures stand at $43.2 million (Q1 2026), $50.5 million (Q4 2025), and $38.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 43.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.23 Mn |
| Dec 31, 2025 | 50.53 Mn |
| Sep 30, 2025 | 38.54 Mn |
| Jun 30, 2025 | 55.63 Mn |
| Mar 31, 2025 | 49.63 Mn |
| Dec 31, 2024 | 66.93 Mn |
| Sep 30, 2024 | 73.40 Mn |
| Jun 30, 2024 | 61.45 Mn |
| Mar 31, 2024 | 79.27 Mn |
| Dec 31, 2023 | 86.62 Mn |
| Sep 30, 2023 | 91.51 Mn |
| Jun 30, 2023 | 124.13 Mn |
| Mar 31, 2023 | 126.02 Mn |
| Dec 31, 2022 | 144.80 Mn |
| Sep 30, 2022 | 154.13 Mn |
| Jun 30, 2022 | 159.46 Mn |
| Mar 31, 2022 | 158.64 Mn |
| Dec 31, 2021 | 164.39 Mn |
| Sep 30, 2021 | 169.06 Mn |
| Jun 30, 2021 | 162.77 Mn |